Annals of Indian Academy of Neurology
  Users Online: 214 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size
This article has been cited by
1A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy
David M. Simpson,Andrew S.C. Rice,Birol Emir,Jaren Landen,David Semel,Marci L. Chew,Jonathan Sporn
Pain.2014;155(10)1943
[DOI]
  About this journal 
  Editorial Board 
  Online Submission 
  Current Issue 
  Archives 
  Ahead of print 
  Instructions to Authors 
  Subscription
  Alerting 
  Feedback 

Submit Articles

Alerts

Join us